323 related articles for article (PubMed ID: 11303185)
1. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
2. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
3. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors.
Dai D; Wolf DM; Litman ES; White MJ; Leslie KK
Cancer Res; 2002 Feb; 62(3):881-6. PubMed ID: 11830547
[TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
5. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
6. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
[TBL] [Abstract][Full Text] [Related]
7. [Endocrinological contribution for invasion and metastasis in gynecological cancers].
Fujimoto J
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by estrogen and insulin-like growth factor-1].
Zhang X; Wei L; Wang J; Tu Z
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):836-9. PubMed ID: 12126534
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
Ai Z; Wang J; Wang Y; Lu L; Tong J; Teng Y
Cancer; 2010 Aug; 116(15):3603-13. PubMed ID: 20564127
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells.
Davies S; Dai D; Wolf DM; Leslie KK
J Soc Gynecol Investig; 2004 Oct; 11(7):494-9. PubMed ID: 15458748
[TBL] [Abstract][Full Text] [Related]
13. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
[TBL] [Abstract][Full Text] [Related]
16. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
17. [Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling].
Hua KQ; Yao LQ; Cao Q; Huang Y; Zhao YQ; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):756-61. PubMed ID: 17327034
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone.
Paulssen RH; Moe B; Grønaas H; Orbo A
Steroids; 2008 Jan; 73(1):116-28. PubMed ID: 18037150
[TBL] [Abstract][Full Text] [Related]
19. [Time-dependent and dose-dependent regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by human insulin-like growth factor-I].
Zhang X; Wei L; Wang J; Tu Z
Zhonghua Fu Chan Ke Za Zhi; 2002 Mar; 37(3):164-7. PubMed ID: 11953087
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
